Shanghai INT Medical Instruments Co (HKSE:01501) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01501 Shanghai INT Medical Instruments Co Ltd HKSE:01501
93 GF Score
Price HK$32.90
GF Value HK$39.95
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shanghai INT Medical Instruments Co FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:01501
93GF Score
Shanghai INT Medical Instruments Co Ltd HKSE:01501
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai INT Medical Instruments Co (HKSE:01501) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai INT Medical Instruments Co stock appears to be undervalued. The current stock price of HK$32.90 is trading 17.6% below its estimated GF Value™ of HK$39.95. GuruFocus considers Shanghai INT Medical Instruments Co to be Modestly Undervalued.

Key valuation signals for HKSE:01501:

  • FFO:
  • GF Value™: HK$39.95 vs. price of HK$32.90 (17.6% below fair value)
  • GF Score™: 93/100 with 4 warning signs

No single metric tells the full story. See the HKSE:01501 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai INT Medical Instruments Co Business Description

Address No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention, or implantation, and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, the United States, and Other countries and regions. The majority of the revenue comes from the Chinese Mainland.
93GF Score

Get the complete analysis for HKSE:01501

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$32.90
Price
HK$39.95
GF Value